UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.11-31

2015

Volltextzugriff (PDF)

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

International journal of radiation oncology, biology, physics, 2014-07, Vol.89 (4), p.854-862

2014

Volltextzugriff (PDF)

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.32-39

2015

Volltextzugriff (PDF)

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2690-2697

2016

Volltextzugriff (PDF)

Keep the Dose Low. Keep the Fields Tight

International journal of radiation oncology, biology, physics, 2020-01, Vol.106 (1), p.15-15

Hoppe, Richard T.

2020

Volltextzugriff (PDF)

20 Gy Versus 30 Gy: Will it Make a Difference?

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.102-103

Hoppe, Richard T.

2019

Volltextzugriff (PDF)

How I treat mycosis fungoides and Sézary syndrome

Blood, 2016-06, Vol.127 (25), p.3142-3153

2016

Volltextzugriff (PDF)

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

Journal of clinical oncology, 2015-11, Vol.33 (32), p.3750-3758

2015

Volltextzugriff (PDF)

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience

Blood, 2013-08, Vol.122 (6), p.981-987

2013

Volltextzugriff (PDF)

Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials

Journal of the American Academy of Dermatology, 2015-02, Vol.72 (2), p.286-292

2015

Volltextzugriff (PDF)

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

Journal of clinical oncology, 2013-02, Vol.31 (6), p.684-691

2013

Volltextzugriff (PDF)

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

Journal of clinical oncology, 2010-10, Vol.28 (28), p.4324-4332

2010

Volltextzugriff (PDF)

Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.40-45

2015

Volltextzugriff (PDF)

Revised Response Criteria for Malignant Lymphoma

Journal of clinical oncology, 2007-02, Vol.25 (5), p.579-586

2007

Volltextzugriff (PDF)

Low-Dose Radiation Therapy (2 Gy × 2) in the Treatment of Orbital Lymphoma

International journal of radiation oncology, biology, physics, 2013-08, Vol.86 (5), p.930-935

2013

Volltextzugriff (PDF)

How I treat mycosis fungoides and Sézary syndrome

Blood, 2009-11, Vol.114 (20), p.4337-4353

2009

Volltextzugriff (PDF)

In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma

Cancer discovery, 2018-10, Vol.8 (10), p.1258-1269

2018

Volltextzugriff (PDF)

Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

The New England journal of medicine, 2008-01, Vol.358 (4), p.362-368

2008

Volltextzugriff (PDF)

Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Journal of clinical oncology, 2014-03, Vol.32 (9), p.912-918

2014

Volltextzugriff (PDF)

Hodgkin lymphoma

Nature reviews. Disease primers, 2020-07, Vol.6 (1), p.61-61, Article 61

2020

Volltextzugriff (PDF)

The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era

Practical Radiation Oncology, 2020-05, Vol.10 (3), p.e147-e154

2020

Volltextzugriff (PDF)

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee

International journal of radiation oncology, biology, physics, 2017-11, Vol.99 (4), p.825-842

2017

Volltextzugriff (PDF)

The solar abundance problem and eMSTOs in clusters

Astronomy and astrophysics (Berlin), 2020-09, Vol.641

2020

Volltextzugriff (PDF)

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Blood, 2007-07, Vol.110 (2), p.479-484

2007

Volltextzugriff (PDF)

How I treat nodular lymphocyte predominant Hodgkin lymphoma

Blood, 2013-12, Vol.122 (26), p.4182-4188

2013

Volltextzugriff (PDF)

1 – 25 von 899

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(675)
Mit Volltextzugriff
(608)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(454)
Life Sciences & Biomedicine
(381)
Humans
(344)
Female
(200)
Male
(199)
Oncology
(173)
Middle Aged
(157)
Adult
(156)
Biological And Medical Sciences
(146)
Medical Sciences
(139)
Aged
(110)
Radiology
(103)
Hematology, Oncology And Palliative Medicine
(92)
Adolescent
(87)
Hematologic And Hematopoietic Diseases
(83)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(80)
Neoplasm Staging
(80)
Prognosis
(71)
Hematology
(68)
Radiology, Nuclear Medicine & Medical Imaging
(67)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG)

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Keep the Dose Low. Keep the Fields Tight

20 Gy Versus 30 Gy: Will it Make a Difference?

How I treat mycosis fungoides and Sézary syndrome

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience

Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study

Expert Radiation Oncologist Interpretations of Involved-Site Radiation Therapy Guidelines in the Management of Hodgkin Lymphoma

Revised Response Criteria for Malignant Lymphoma

Low-Dose Radiation Therapy (2 Gy × 2) in the Treatment of Orbital Lymphoma

How I treat mycosis fungoides and Sézary syndrome

In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma

Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Hodgkin lymphoma

The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee

The solar abundance problem and eMSTOs in clusters

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

How I treat nodular lymphocyte predominant Hodgkin lymphoma

Suchergebnisse filtern